Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alcon Group Says Novartis Bid 'Inadequate'
TheStreet.com
Wednesday, January 20, 2010 - 9:15am
tags:
Novartis, M&A, Alcon
If Approved -- FDA Drug Labeling Could Decide Ultimate Success of MannKind's Afrezza
BNET Pharma
Wednesday, January 20, 2010 - 9:13am
tags:
MannKind, Afrezza, inhaled insulin, diabetes
Glaxo’s Witty Gives Away Malaria Drug Research as Vaccine Nears
Bloomberg
Wednesday, January 20, 2010 - 9:12am
tags:
Andrew Witty, GSK, vaccines, malaria
Health Stocks Gain Worldwide as Outlook Fades for U.S. Revamp
Bloomberg
Wednesday, January 20, 2010 - 9:11am
tags:
healthcare reform
Pfizer’s Looking for More Sales Reps. In China.
WSJ Online
Wednesday, January 20, 2010 - 9:11am
tags:
Pfizer, drug reps, China
Lilly changes course as it shrinks its sales force
Indianapolis Star, IN
Tuesday, January 19, 2010 - 9:19pm
tags:
Eli Lilly, layoffs, drug reps
Novartis, GenVec to develop hearing-loss treatment in $214M deal
Bizjournals.com
Tuesday, January 19, 2010 - 9:17pm
tags:
hearing loss, Novartis, GenVec, partnerships
Encouraging Results from Bionovo
Yahoo/Zacks.com
Tuesday, January 19, 2010 - 9:15pm
tags:
Bionovo, Bezielle
Wyeth Won't Market Sleeplessness Treatment
Forbes
Tuesday, January 19, 2010 - 9:14pm
tags:
Wyeth, insomnia, Pfizer
Watson Confirms Filing of FDA Application for Generic Lidoderm
CNN Money
Tuesday, January 19, 2010 - 10:16am
tags:
lidoderm, generics, FDA, Watson Pharmaceuticals
Pharma's vaccine epidemic
Investors Chronicle
Tuesday, January 19, 2010 - 10:15am
tags:
vaccines, GSK
Indian biotech exec predicts a $10B industry boomInd
Fierce Biotech
Tuesday, January 19, 2010 - 10:08am
tags:
India, biotech
Glaxo troubled by flu cuts, fake Alli
Fierce Pharma
Tuesday, January 19, 2010 - 10:06am
tags:
Alli, GSK, swine flu, vaccines, H1N1
The Top Biotech Layoffs of 2009...and a Silver Lining
BNET Pharma
Tuesday, January 19, 2010 - 9:42am
tags:
biotech, layoffs, Sepracor, Allergan, Genmab, Oscient, Amylin
Musings on Commando Teva: Besting Big Pharma?
InVivo
Tuesday, January 19, 2010 - 9:41am
tags:
Teva Pharmaceuticals
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tuesday, January 19, 2010 - 9:39am
tags:
Adventrx, Genentech, Novartis, Amgen, Pfizer, Novelos Therapeutics, ONYX Pharmaceuticals
Genzyme: Shire Chomping at the Bit
Seeking Alpha
Tuesday, January 19, 2010 - 9:36am
tags:
Shire, Genzyme, Amicus Therapeutics
New Illumina Genome Sequencer Dramatically Slashes Costs, Time
Seeking Alpha
Tuesday, January 19, 2010 - 9:34am
tags:
Illumina, genome sequencer, Helicos, Life Technologies
Pfizer, Teva set to tussle for Ratiopharm
Reuters
Tuesday, January 19, 2010 - 9:32am
tags:
Teva Pharmaceuticals, Pfizer, Ratiopharm, M&A
AspenBio Pharma Poised for a Breakout Year
Seeking Alpha
Tuesday, January 19, 2010 - 9:30am
tags:
AspenBio

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.